Management of Chronic Plaque Psoriasis through Panchkarma: A case report.

IF 1.7 Q3 INTEGRATIVE & COMPLEMENTARY MEDICINE
Rohan Agalcha, Sarvesh Kumar Singh, Kshipra Rajoria
{"title":"Management of Chronic Plaque Psoriasis through Panchkarma: A case report.","authors":"Rohan Agalcha, Sarvesh Kumar Singh, Kshipra Rajoria","doi":"10.1016/j.jaim.2024.101072","DOIUrl":null,"url":null,"abstract":"<p><p>Psoriasis is a chronic systemic inflammatory skin disorder prevailing in 2%-3% individuals worldwide. Yet no permanent management has been established. Metabolic burdens and comorbidities have been found to be associated with Psoriasis, which make it more critical. The classical management of the disease in Ayurveda includes Vamana Karma (therapeutic emesis) and Virechana Karma (therapeutic purgation). This is a distinct case where a 52-year-old patient, suffering from Chronic Plaque Psoriasis (CPP), unfit for Vamana Karma was treated by VirechanaKarma only. The patient had suffered from Psoriasis since last 14 years and was present with symptoms of scaly lesions and intense itching. The patient was admitted in the IPD and planned for Virechana Karma. After Shodhana, Rasamanikya-125 mg, Vidanga Choorna 2 gm, Kaishora Guggulu-1000 mg, Kamdudha Rasa 250 mg, Khadirarishta-20 ml, and Punarnavadi Kwatha 40 ml, twice a day was advised with daily 3 times local application of Bruhad Marichyadi Taila as regular medication. The assessment was done by Psoriasis Area Severity Index (PASI) score, Dermatology Life Quality Index (DLQI) score and Numerical Rating Scale (NRS) for itching. The initial PASI, DLQI and NRS scores were 20.6, 18, and 8 respectively which was evaluated to be, 5.8, 4 and 2 respectively in the latest follow-up. This case study demonstrates that Virechana alone may also manage CPP.</p>","PeriodicalId":15150,"journal":{"name":"Journal of Ayurveda and Integrative Medicine","volume":"16 1","pages":"101072"},"PeriodicalIF":1.7000,"publicationDate":"2025-01-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Ayurveda and Integrative Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.jaim.2024.101072","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}
引用次数: 0

Abstract

Psoriasis is a chronic systemic inflammatory skin disorder prevailing in 2%-3% individuals worldwide. Yet no permanent management has been established. Metabolic burdens and comorbidities have been found to be associated with Psoriasis, which make it more critical. The classical management of the disease in Ayurveda includes Vamana Karma (therapeutic emesis) and Virechana Karma (therapeutic purgation). This is a distinct case where a 52-year-old patient, suffering from Chronic Plaque Psoriasis (CPP), unfit for Vamana Karma was treated by VirechanaKarma only. The patient had suffered from Psoriasis since last 14 years and was present with symptoms of scaly lesions and intense itching. The patient was admitted in the IPD and planned for Virechana Karma. After Shodhana, Rasamanikya-125 mg, Vidanga Choorna 2 gm, Kaishora Guggulu-1000 mg, Kamdudha Rasa 250 mg, Khadirarishta-20 ml, and Punarnavadi Kwatha 40 ml, twice a day was advised with daily 3 times local application of Bruhad Marichyadi Taila as regular medication. The assessment was done by Psoriasis Area Severity Index (PASI) score, Dermatology Life Quality Index (DLQI) score and Numerical Rating Scale (NRS) for itching. The initial PASI, DLQI and NRS scores were 20.6, 18, and 8 respectively which was evaluated to be, 5.8, 4 and 2 respectively in the latest follow-up. This case study demonstrates that Virechana alone may also manage CPP.

通过Panchkarma治疗慢性斑块型银屑病1例。
牛皮癣是一种慢性全身性炎症性皮肤病,在全球范围内患病率为2%-3%。然而,目前还没有建立永久性的管理机构。代谢负担和合并症已被发现与牛皮癣有关,这使得它更加重要。在阿育吠陀经典管理的疾病包括Vamana业力(治疗呕吐)和Virechana业力(治疗性净化)。这是一个独特的病例,52岁的患者,患有慢性斑块性银屑病(CPP),不适合Vamana Karma治疗,仅用VirechanaKarma治疗。患者自过去14年以来一直患有牛皮癣,并出现鳞状病变和强烈瘙痒的症状。患者入住IPD并计划进行Virechana Karma治疗。在Shodhana后,Rasamanikya-125毫克,Vidanga Choorna 2克,Kaishora Guggulu-1000毫克,Kamdudha Rasa 250毫克,khadirarishta 20毫升,Punarnavadi Kwatha 40毫升,建议每天两次,每日3次局部应用Bruhad Marichyadi Taila作为常规药物。采用银屑病区域严重程度指数(PASI)评分、皮肤病生活质量指数(DLQI)评分和瘙痒数值评定量表(NRS)进行评估。初始PASI、DLQI和NRS评分分别为20.6分、18分和8分,最新随访评估分别为5.8分、4分和2分。本案例研究表明,Virechana也可以单独管理CPP。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Ayurveda and Integrative Medicine
Journal of Ayurveda and Integrative Medicine INTEGRATIVE & COMPLEMENTARY MEDICINE-
CiteScore
4.70
自引率
12.50%
发文量
136
审稿时长
30 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信